InvestorsHub Logo

Charleston

05/11/18 6:56 AM

#5152 RE: Leronlimab4DaWin #5151

The safety profile is reviewed by the FDA and given a continuation after careful review of the circumstance. It granted Fast Track Designation.

Raising capital is a signal of the Opt In decision after Janssen's continuation announcement. The golden age for Geron is beginning with this ramp up

healthywelth

05/11/18 8:55 AM

#5155 RE: Leronlimab4DaWin #5151

LIAR....... GERON The safety profile is reviewed by the FDA and given a continuation after careful review of the circumstance. It granted Fast Track Designation. NICE TRY .....